Skip to main content
. 2020 Oct 19;38(49):7697–7701. doi: 10.1016/j.vaccine.2020.10.039

Fig. 2.

Fig. 2

Peptide S1526–533 is identified as the H2-Dd-restricted CD8+ CTL epitope. (A, B) BALB/c mice were immunized with the S1 protein twice weekly. Splenocytes were obtained and specific T-cell induction was analyzed with intracellular cytokine staining assays, using stimulation with the indicated peptides. (B) The avidity of the induced S-RBD-specific CD8+ T cells was analyzed with intracellular cytokine staining assays, using stimulation by graded doses of the peptides (ranging from 1 to 0.003 µM). (C) BALB/c mice were immunized with the S1 protein twice weekly. Splenocytes were obtained and specific T-cell induction was stimulated with S1526–533 peptides. MHC restriction of the induced S-RBD-specific CD8+ T cells was analyzed with the intracellular cytokine staining assay after the addition of anti-H2-Kd/Dd or anti-H2-Kd mAbs. These experiments were repeated two times with similar results. Data are the mean ± SD.